Studies of multimerin in patients with von Willebrand disease and platelet von Willebrand factor deficiency

被引:6
|
作者
Chen, CI
Federici, AB
Cramer, EM
Canciani, MT
Harrison, P
Zheng, SL
Massé, JM
Mannucci, PM
Hayward, CPM
机构
[1] McMaster Univ, Dept Pathol, Hamilton, ON L8N 3Z5, Canada
[2] McMaster Univ, Dept Lab Med, Hamilton, ON L8N 3Z5, Canada
[3] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada
[4] Hamilton Hlth Sci Corp, Hamilton, ON, Canada
[5] Maggiore Hosp, IRCCS, Angelo Bianchi Bonomi Haemophilia & Thrombosis Ct, Milan, Italy
[6] Maggiore Hosp, IRCCS, Inst Internal Med, Milan, Italy
[7] Univ Milan, Milan, Italy
[8] Hop Henri Mondor, INSERM, U91, F-94010 Creteil, France
[9] UCL Hosp, Dept Haematol, London, England
关键词
platelets; von Willebrand factor; von Willebrand disease; multimerin; granules;
D O I
10.1046/j.1365-2141.1998.00943.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In normal platelet alpha-granules von Willebrand factor (VWF) is stored with multimerin and factor V in an eccentric electron-lucent zone. Because the platelet stores of VWF are deficient in 'platelet low' type 1 and type 3 von Willebrand disease (VWD), we investigated their electron-lucent zone proteins. The patients with VWD had partial to complete deficiencies of plasma and platelet VWF but normal alpha-granular multimerin and factor V, and normal alpha-granular fibrinogen, thrombospondin-1, fibronectin, osteonectin and P-selectin. In type 3 VWD platelets, alpha-granular electron-lucent zones lacking VWF-associated tubules were identified and multimerin was found in its normal alpha-granular location, These findings indicate that the formation of the electron-lucent zone and the sorting of multimerin to this region occur independent of VWF. The isolated abnormalities in VWF suggests a VWF gene mutation is the cause of 'platelet low' type 1 VWD.
引用
收藏
页码:20 / 28
页数:9
相关论文
共 50 条
  • [21] PLATELET MEMBRANE VON WILLEBRAND FACTOR
    GREEN, D
    POTTER, EV
    [J]. BLOOD, 1978, 52 (04) : 856 - 857
  • [22] Von Willebrand factor contribution to pathophysiology outside of von Willebrand disease
    Mojiri, Anahita
    Alavi, Parnian
    Jahroudi, Nadia
    [J]. MICROCIRCULATION, 2019, 26 (04)
  • [23] Combination of von Willebrand disease and factor XII deficiency
    Bux-Gewehr, I
    Morgenschweis, K
    Zotz, RB
    Budde, U
    Scharf, RE
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, : 284 - 285
  • [24] PHARMACOKINETIC MODELING OF THE VON WILLEBRAND FACTOR - FACTOR VIII INTERACTION IN PERIOPERATIVE VON WILLEBRAND DISEASE PATIENTS
    Bukkems, L. H.
    Heijdra, J.
    de Jager, N.
    Hazendonk, H.
    Fijnvandraat, K.
    Meijer, K.
    Eikenboom, J.
    Laros-van Gorkom, B.
    Leebeek, F.
    Cnossen, M.
    Mathot, R.
    [J]. HAEMOPHILIA, 2021, 27 : 147 - 147
  • [25] Quantification of von Willebrand Factor and von Willebrand Factor Propeptide in Patients with End Stage Renal Disease
    Davis, Rachael
    Bansal, Vinod
    Litinas, Evangelos
    Rahman, Saudur
    Hoppensteadt, Debra
    Conway, Brooke
    Fareed, Jawed
    [J]. FASEB JOURNAL, 2010, 24
  • [26] The Course of von Willebrand Factor and Factor VIII Activity in Patients with von Willebrand Disease during Pregnancy
    Delbrueck, Christiane
    Miesbach, Wolfgang
    [J]. ACTA HAEMATOLOGICA, 2019, 142 (02) : 71 - 78
  • [27] Unraveling von Willebrand factor deficiency
    Hayward, Catherine P. M.
    [J]. BLOOD, 2021, 137 (23) : 3160 - 3161
  • [28] Population pharmacokinetics of the von Willebrand factor-factor VIII interaction in patients with von Willebrand disease
    Bukkems, Laura H.
    Heijdra, Jessica M.
    de Jager, Nico C. B.
    Hazendonk, Hendrika C. A. M.
    Fijnvandraat, Karin
    Meijer, Karina
    Eikenboom, Jeroen C. J.
    Laros-van Gorkom, Britta A. P.
    Leebeek, Frank W. G.
    Cnossen, Marjon H.
    Mathot, Ron A. A.
    [J]. BLOOD ADVANCES, 2021, 5 (05) : 1513 - 1522
  • [29] Von Willebrand factor deficiency and atherosclerosis
    van Galen, K. P. M.
    Tuinenburg, A.
    Smeets, E. M.
    Schutgens, R. E. G.
    [J]. BLOOD REVIEWS, 2012, 26 (05) : 189 - 196
  • [30] Von Willebrand disease: Assessing platelet von Willebrand factor and other variables in patients with presumed type 1 VWD.
    Konkle, BA
    Tarng, HI
    [J]. BLOOD, 2002, 100 (11) : 494A - 494A